Vitis vinifera as a medicinal plant

Acta Horticulturae

Volumn 597, Issue , 2004, Pages 159-165

  Tyihak E ^a   Katay Gy ^a   Kiraly Veghely Zs ^b   Nemeth Zs ^c   Albert, L ^c   Szende, B ^d  

^a INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^b FVM Szoleszeti es Boraszati Kutatointezete Kecskemet   (Hungary)

^c UNIVERSITY OF WEST HUNGARY   (Hungary)

^d SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Double effect; Formaldehyde; Interaction; Phytoalexin; Resveratrol

Indexed keywords

EID: 84879648594     PISSN: 05677572     EISSN: None     Source Type: Book Series    
DOI: 10.17660/ActaHortic.2003.597.22     Document Type: Conference Paper

References (30)

1. Arichi, H., Kimura, Y., Okuda, H., Bab, K., Kozawa, M. and Arachi, S. 1982. Effects of stilbene compounds of the roots of Polygonum cuspidatum Sieb. et Succ. on lipid metabolism. Chem. Pharm. Bull. 30:1766-1770.
2. Bertelli, A. A. E., Giovannini, L., Guiannessi, D., Migliori, M., Bernini, W., Fregoni, M. and Bertelli A. 1995.. Antiplatelet activity of synthetic and natural resveratrol in red wine. Int. J. Tiss. Reac. 17:1-3.
3. Cheong, H., Ryu, S. Y. and Kim, K. M. 1999. Anti-allergic action of resveratrol and related hydroxystilbenes. Planta Med. 65:266-268.
4. Frankel, E. N., Waterhouse, A. L. and Kinsella, J. E. 1993. Inhibition of human LDL oxidation by resveratrol. The Lancet 341:1103-1104.
5. Fremont, L., Belguendouz, V. and Delpal, S. 1999. Antioxidant activity of resveratrol and alcohol-free wine polyphenols related to LDL oxidation and polyunsaturated fatty acids. Life Sci. 26:2511-2521.
6. Gautam, S. C., Xu, Y. X., Dumaguin, M., Janakiraman, N. and Chapman, R. A. 2000. Resveratrol selectively inhibits leukemia cells: a prospective agent for ex vivo bone marrow purging. Bone Marrow Transplant. 25:639-645.
7. Gentilli, M., Mazoit, J. X., Bouaziz, H., Fletcher, D., Casper, R. F., Benhamou, D. and Savouret, J. F. 2001. Resveratrol decreases hyperalgesia induced by carrageenan in the rat hind paw. Life Sci. 68:1317-1321.
8. Hain, R., Reif, H-J., Krause, E., Langebartels, R., Kind, H., Vornam, B., Wiese, W., Schmelzer, E., Stocker, R. H. and Stenzel, K. 1993 Disease resistance results from foreign phytoalexin expression in a novel plant. Nature 361:153-156.
9. Heck, H., Casanova, M. and Starr, T. B. 1990. Formaldehyde toxicity-New understanding. Crit. Rev. Toxicol. 20:397-426.
10. 3H) methionine during enzymic transmethylation of histamine. FEBS Lett. 209:362-366.
11. Ingham, J. L. 1976. 3, 5, 4'-Trihydroxystilbene as a phytoalexin from groundnuts (Arachis hypogea). Phytochemistry 15:1791-1793.
12. Jager, U. and Nguyen-Duong, H. 1999. Relaxant effect of trans-resveratrol on isolated porcine coronary arteries. Arznm.-Forschg. 49:207-211.
13. Jang, M., Cai, L., Udeani, G. O., Slowing, K. V., Thomas, C. F., Beecher, C. W., Fong, H. H., Farnsworth N. R., Kinghorn A. D., Mehta R. G., Moon R. C. and Pezzuto J. M. 1997. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275:218-220.
14. Kerry, N. L. and Abbey, M. 1997. Red wine and fractionated compounds preparated from red wine inhibit low-density lipoprotein oxidation in vitro. Atherosclerosis 135:93-102.
15. Kiraly-Veghely, Zs., Tyihak, E., Albert, L., Nemeth, Zs. I. and Katay, Gy. 1998. Identification and measurement of resveratrol and formaldehyde in parts of white and blue grape berries. Acta Biol. Hung. 49:281-289.
16. Langcake, P. and Pryce, R. J. 1976. The production of resveratrol by Vitis vinifera and other members of the Vitaceae as a response to infection or injury. Physiol. Plant Pathol. 9:77-86.
17. MacCarrone, M., Lorenzen, T., Guerrieri, P. and Agro. A. F. 1999). Resveratrol preventsapoptosis in K562 cells by inhibiting lipoxygenase and cyclooxygenase activity. Eur. J. Biochem. 265:27-34.
18. Renaud, S. and de Lorgeril, M. 1992 Wine alcohol, platelets and the French paradox for coronary heart disease. Lancet 339:1523-1526.
19. Siemann, E. H. and Creasy, L. L. 1992. Concentration of the phytoalexin resveratrol in wine. Am. J. Enol. Vitic. 43:49-52.
20. Spencer, D. and Henshall, T. 1955. The kinetics and mechanisms of the reaction of formaldehyde with dimedone (Part I). J. Am. Chem. Soc. 77:1943-1948.
21. Szende, B., Tyihák, E., Trézl, L., Szoke, E., László, I., Kátay, Gy. and Király-Véghely, Zs. 1999. Formaldehyde generators and capturers as influencing factors of mitotic and apoptotic processes. Acta Biol. Hung. 49:323-329.
22. st Hung. Annu. Meet. Biochem., Veszprem, Hungary, Hung. Biochem. Soc., Rosdy, B. (ed.), Budapest, Chem. Abstr. 96:159 825b, 1982.
23. Turner, R. T., Evans, G. L., Zhang, M., Maran, A. and Sibonga, J. D. 1999. Is resveratrol an estrogen agonist in growing rats? Endocrinol. 140:50-54.
24. Turrens, J. F., Larisccia, J. and Nair, M. G. 1997. Resveratrol has no effect on lipoprotein profile and does not prevent peroxidation of serum lipids in normal rats. Free Rad. Res. 27:557-562.
25. Tyihák, E. Trézl, L. and Szende, B. 1998 a. Formaldehyde cycle and the phases of stress syndrome. N. Y. Acad. Sci. 851:259-270.
26. Tyihák, E., Albert, L., Németh., Zs. I., Kátay, Gy., Király-Véghely, Zs. and Szende, B. 1998b. Formaldehyde cycle and the natural formaldehyde generators and capturers. Acta Biol. Hung. 49:225-238.
27. Uenobe, F., Nakamura, Si. and Miyazawa, M. 1997. Antimutagenic effect of resveratrol against Trp-P-1. Mut. Res. 373:197-200.
28. Virgili, M. and Contestabile, A. 2000. Partial neuroprotection of in vivo excitotoxic brain damage by chronic administration of the red wine antioxxidant agent, transresveratrol in rats. Neurosci. Lett. 10:123-126.
29. Whittal, R. M. and Li, L. 1998. Time-lag focusing MALDI-TOF mass spectrometry. Intern. Lab., September, 41-47.
30. Yu, P. H. 1997. Deamination of methylamine and angiopathy: toxicity of formaldehyde, oxidative stress and relevance to protein glycoxidation in diabetes. J. Neural. Transm. 52:207-222.